BIT's 17th Annual Congress of International Drug Discovery Science and Technology (IDDST-2019)
Scientific Program
Scientific Program
Stream 1 Stream 2 Stream 3 Stream 4 Stream 5

 

Keynote Forum

Day 1: Morning, Thursday, July 25, 2019

Place: Room A, 2nd Floor

09:15-12:15

Moderator: Dr. Matthias von Herrath, Professor, La Jolla Institute; Vice President, NovoNordisk, USA

Time Speeches and Speakers
09:15-09:20

Moderator's Introduction

09:20-09:45

Title: Challenge for Drug Discovery in Japan: Open Innovation and Network
Dr. Yoshinori Ikeura, CEO/CSO, Axcelead Drug Discovery Partners, Inc., Japan

09:45-10:10

Title: Harnessing Potent Cytokine Agonist Pathways by Polymer Engineering to Develop Novel Immune Therapeutic Agents
Dr. Loui Madakamutil, SVP, Head of Biology and Preclinical Development, Nektar Therapeutics, USA

10:10-10:35

Title: Pathology of Type 1 Diabetes and New Therapeutic Approaches – An Update
Dr. Matthias von Herrath, Professor, La Jolla Institute; Vice President, NovoNordisk, USA

10:35-11:00 Title: Role of Microglia in Evoking Neuropathic Pain
Dr. Kazuhide Inoue, Executive Vice President, Kyushu University, Japan
11:00-11:25

Sponsor

Title: Improving Biologics Workflow: Detailed Characterization of Quality, Binding and Stability of mAbs
Dr. Zhuo Li, General Manager, NanoTemper China, China
11:25-11:50 Title: Issues and Challenges in Drug Development
Dr. Michael Gamlen, Chief Scientific Officer, Gamlen Tableting Ltd., UK
12:00-13:00 Lunch

© 2003-2019 All rights reserved by BIT Group Global Ltd.
Contact Us: Tel: 0086-411-84799609, Fax: 0086-411-84796897